rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

Ventas, Inc.

VTR · NYSE

Real EstateREITsNot moving yetLongevity Biotech

VTR stood above a rising 150-day average in 46 of the last 52 weekly readings, and has been out of that trend for the last 5 weeks. It is 3.6% below that average now. REITs: 10% of its 169 stocks in an uptrend (−13 points in four weeks); Real Estate: 9% (−15 points in four weeks).

Statistics

Rotation
Not moving yet
Weeks in an uptrend
out for 5
Industry in uptrend
10% -13 in 4 wk
Insider buys, 12 months
$394K
Insider sales, 12 months
$50.6M
Officials’ trades on record
32

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 46 of 52 weeks.

20 Apr – 19 Oct
11%33%55%Apr 26Jun 26Jul 26Sep 26Oct 26

REITs: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Real Estate: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026
−$38.7M$0Nov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars. Not yet read: institutions.

Congress and officials

32 disclosed lines: House 27, Senate 3, executive 2; 16 people.

WhoDidAmountTraded
Donald J. Trump Executive branch: Office of Government EthicsWhite House Officesold$1k–$15k27 Apr 2026filed 1 Jul 2026
Alan Armstrong Senate: U.S. Senate eFDSenatorbought$1k–$15k27 Mar 2026filed 21 Jul 2026
Donald J. Trump Executive branch: Office of Government EthicsWhite House Officebought$1k–$15k23 Mar 2026filed 14 May 2026
Gilbert Ray Cisneros, Jr. House: U.S. House ClerkCA31sold$1k–$15k9 Jan 2026filed 13 Feb 2026
Gilbert Ray Cisneros, Jr. House: U.S. House ClerkCA31bought$1k–$15k12 Nov 2025filed 15 Dec 2025
Earl Blumenauer House: U.S. House ClerkOR03soldspouse$15k–$50k19 Sep 2024filed 8 Oct 2024
Daniel S. Goldman House: U.S. House ClerkNY10sold$1k–$15k14 Jul 2023filed 13 Aug 2023
Daniel S. Goldman House: U.S. House ClerkNY10sold$15k–$50k10 Apr 2023filed 19 May 2023
Earl Blumenauer House: U.S. House ClerkOR03sold$1k–$15k14 Mar 2022filed 1 Apr 2022
Earl Blumenauer House: U.S. House ClerkOR03bought$15k–$50k23 Feb 2022filed 7 Mar 2022
Earl Blumenauer House: U.S. House ClerkOR03bought$1k–$15k18 Feb 2022filed 1 Apr 2022
Gilbert Ray Cisneros, Jr. House: U.S. House ClerkCA39bought$1k–$15k29 Apr 2020filed 13 May 2020

Insiders

Buy orders, 12 months1
Sale orders, 12 months20
Buyers · sellers1 · 5
WhoDidSharesTraded
Michael J. EmblerDirectorbought2,500at $78.813 Jun 2026filed 5 Jun 2026
Walter C. RakowichDirectorsold1,152at $90.2014 May 2026filed 15 May 2026
Carey S. RobertsEVP and GCsold35,532at $85.0011 Feb 2026filed 13 Feb 2026
Debra A. CafaroChairman and CEOsold10,322at $82.236 Feb 2026filed 10 Feb 2026
Debra A. CafaroChairman and CEOsold10,322at $77.662 Feb 2026filed 3 Feb 2026
Debra A. CafaroChairman and CEOsold10,322at $77.262 Jan 2026filed 6 Jan 2026
Robert F. ProbstEVP and CFOsold29,930at $77.252 Jan 2026filed 6 Jan 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Still reading this part; it fills in a moment.

Everyone who traded it

Joe Vasquez Rodriguez Jr. Company insiderDirector · last 15 Oct 20260 · 0
Marguerite M. Nader Company insiderDirector · last 15 Oct 20260 · 0
Matthew J. Lustig Company insiderDirector · last 15 Oct 20260 · 2
Maurice S. Smith Company insiderDirector · last 15 Oct 20260 · 0
Melody C. Barnes Company insiderDirector · last 15 Oct 20260 · 1
Michael J. Embler Company insiderDirector · last 15 Oct 20261 · 0
Roxanne M. Martino Company insiderDirector · last 15 Oct 20260 · 0
Sumit Roy Company insiderDirector · last 15 Oct 20260 · 0
Laurida Sayed Company insiderSVP, Chief Accounting Officer · last 5 Oct 20260 · 0
Andy Wattula Company insiderEVP OM&R-Ventas/Pres&CEO-LHS · last 1 Aug 20260 · 0
Walter C. Rakowich Company insiderDirector · last 14 May 20260 · 4
Sean P. Nolan Company insiderDirector · last 13 May 20262 · 0

Same industry

CXW CoreCivicLeading+9%

Distance from each stock’s own 150-day average.

Government contracts

No federal award is tied to it.

From its SEC filings

Free cash flow marginFY 2025 · to 31 Dec 2025-22.0%
Debt to equityFY 2025 · to 31 Dec 20251.04×
Share count trendFY 2025 · to 3 Feb 20262.7%
Cash and equivalentsFY 2025 · to 31 Dec 2025$741.1M
Free cash flowFY 2025 · to 31 Dec 2025−$1.3B

Analyst forecasts

No analyst forecasts yet.